Tenet Healthcare Corporation New vs Abbvie Inc.
THC vs ABBV — side-by-side comparison from reported financials. THC leads 6, ABBV leads 4 of 10 comparable metrics.
Tenet Healthcare Corporation New
THC · Healthcare
$264.31+1.44%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | THC | ABBV |
|---|---|---|
| Price | $264.31 | $276.43 |
| Market cap | $21.3B | $488B |
| Revenue (TTM) | $21.8B | $64.4B |
| Revenue growth | +3.6% | +1.8% |
| Net margin | 10.3% | 9.8% |
| Free cash flow | $3.02B | $18.2B |
| Net cash (debt) | ($10.3B) | ($56.2B) |
| 1-year price return | +35.6% | +19.8% |
| P/E | 9.5 | 77.4 |
| P/E vs own history (cheap-side %) | 50% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | 51% | 96% |
| Altman Z-score | 1.51 | 2.33 |
| CV checks passed | 9 of 10 | 9 of 10 |
| Employees | 99,000 | 57,000 |
Full résumé-style profiles: THC CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.